Cargando…

Performance and comparison of assessment models to predict 30-day mortality in patients with hospital-acquired pneumonia

BACKGROUND: Hospital-acquired pneumonia (HAP) is the most common hospital-acquired infection in China with substantial morbidity and mortality. But no specific risk assessment model has been well validated in patients with HAP. The aim of this study was to investigate the published risk assessment m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Jia-Ning, Li, Nan, Guo, Chen-Xia, Shen, Ning, He, Bei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752693/ https://www.ncbi.nlm.nih.gov/pubmed/33278090 http://dx.doi.org/10.1097/CM9.0000000000001252

Ejemplares similares

The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2005)

Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital
por: Akagi, Takanori, et al.
Publicado: (2019)

The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2005)

The association between serum magnesium levels and community-acquired pneumonia 30-day mortality
por: Nasser, Roni, et al.
Publicado: (2018)

Serum inorganic phosphorus levels predict 30-day mortality in patients with community acquired pneumonia
por: Naffaa, Mohammad E., et al.
Publicado: (2015)

Incidence of Avoidable 30-Day Readmissions Following Hospitalization for Community-Acquired Pneumonia in France
por: Boussat, Bastien, et al.
Publicado: (2022)

Impact of frailty on 30-day and 1-year mortality in hospitalised elderly patients with community-acquired pneumonia: a prospective observational study
por: Luo, Jia, et al.
Publicado: (2020)

Ability of the LACE index to predict 30-day hospital readmissions in patients with community-acquired pneumonia
por: Dobler, Claudia C., et al.
Publicado: (2020)

Predictors of 30-day readmission following hospitalisation with community-acquired pneumonia
por: Chakrabarti, Biswajit, et al.
Publicado: (2021)

Effect on 30-day mortality and duration of hospitalization of empirical antibiotic therapy in CRGNB-infected pneumonia
por: Li, Rongrong, et al.
Publicado: (2021)

The Global Comparators project: international comparison of 30-day in-hospital mortality by day of the week
por: Ruiz, Milagros, et al.
Publicado: (2015)

An Administrative Claims Model for Profiling Hospital 30-Day Mortality Rates for Pneumonia Patients
por: Bratzler, Dale W., et al.
Publicado: (2011)

The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia
por: Reade, Michael C, et al.
Publicado: (2010)

Influence of overweight and obesity on the mortality of hospitalized patients with community-acquired pneumonia
por: Wang, Ning, et al.
Publicado: (2022)

Variation in Acute Care Rehabilitation and 30-Day Hospital Readmission or Mortality in Adult Patients With Pneumonia
por: Freburger, Janet K., et al.
Publicado: (2020)

Disease Severity and Risk Factors of 30-Day Hospital Readmission in Pediatric Hospitalizations for Pneumonia
por: Lewis, Motomori O., et al.
Publicado: (2022)

Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19
por: Satici, Celal, et al.
Publicado: (2020)

Performance of Predictive Models for 30-Day Hospitalization and Mortality after COVID-19 Infection
por: Myers, Laura C., et al.
Publicado: (2022)

Clinical and Bacterial Characteristics of Klebsiella pneumoniae Affecting 30-Day Mortality in Patients With Bloodstream Infection
por: Wu, Xingbing, et al.
Publicado: (2021)

A Clinical Predictor Score for 30-Day Mortality among HIV-Infected Adults Hospitalized with Pneumonia in Uganda
por: Koss, Catherine A., et al.
Publicado: (2015)

Prediction of 30-Day Mortality Using the Quick Pitt Bacteremia Score in Hospitalized Patients with Klebsiella pneumoniae Infection
por: Su, Ching, et al.
Publicado: (2023)

Bacterial etiology and mortality rate in community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia in Thai university hospital
por: Poovieng, Jaturon, et al.
Publicado: (2022)

Factors affecting 90-day mortality in community and hospital acquired pneumonia patients with or without acute kidney injury
por: Hoşgün, Derya, et al.
Publicado: (2022)

An administrative model for benchmarking hospitals on their 30-day sepsis mortality
por: Darby, Jennifer L., et al.
Publicado: (2019)

Early predicting 30-day mortality in sepsis in MIMIC-III by an artificial neural networks model
por: Su, Yingjie, et al.
Publicado: (2022)

Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
por: Motowski, Hayley, et al.
Publicado: (2023)

A Broad Learning System to Predict the 28-Day Mortality of Patients Hospitalized with Community-Acquired Pneumonia: A Case-Control Study
por: Yuan, Jing, et al.
Publicado: (2022)

Plasma lipid profiling for the prognosis of 90-day mortality, in-hospital mortality, ICU admission, and severity in bacterial community-acquired pneumonia (CAP)
por: Banoei, Mohammad M., et al.
Publicado: (2020)

The Performance of CURB-65 and PSI for Predicting In-Hospital Mortality of Community-Acquired Pneumonia in Patients with Type 2 Diabetes Compared with the Non-Diabetic Population
por: Ma, Chun-Ming, et al.
Publicado: (2021)

Relation between red blood cell distribution width and 30-day in-hospital mortality of patients with ventilator-associated pneumonia
por: Li, Zhonghua, et al.
Publicado: (2023)

Prediction of 30-Day Mortality Using the Quick Pitt Bacteremia Score in Hospitalized Patients with Klebsiella pneumoniae Infection [Letter]
por: Yang, Huiyan, et al.
Publicado: (2023)

Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumonia
por: Baumgartner, Thomas, et al.
Publicado: (2018)

Antibiotic prescription consistent with guidelines in emergency department is associated with 30-day survival in severe community-acquired pneumonia
por: Kang, Seung Hyun, et al.
Publicado: (2021)

805 Predictors of 30-day hospital readmission in patients with community-onset pneumonia
por: Gross, Alan E., et al.
Publicado: (2014)

A Cool Drink on a Hot Day – Hospital-Acquired Legionella Pneumonia
por: Krystofiak, S.P.
Publicado: (2006)

879. Intravenous to Oral Antibiotic Switch in Patients Hospitalized with Community-Acquired Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2022)

Risk Factors of 30-Day All-Cause Mortality in Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection
por: Liu, Keh-Sen, et al.
Publicado: (2021)

Severe community-acquired pneumonia: risk factors for in-hospital mortality
por: Pereira, JM, et al.
Publicado: (2012)

Factors Associated with Mortality in Immunocompetent Patients with Hospital-acquired Pneumonia
por: Sangmuang, Pavaruch, et al.
Publicado: (2019)

Prediction of 30-Day Mortality Using the Quick Pitt Bacteremia Score in Hospitalized Patients with Klebsiella pneumoniae Infection [Response to Letter]
por: Su, Ching, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_88ar789hcgppu3uhtmvtkaejhn